Stanford Institute for Stem Cell Biology and Regenerative Medicine

Stanford Institute for Stem Cell Biology and Regenerative Medicine The Stanford Institute for Stem Cell Biology and Regenerative Medicine's home is located in the Lorry I. Lokey Stem Cell Research Building, the largest stem cell research building in the United States.
(9)

Operating as usual

Institute researcher Vittorio Sebastiano shows that aged human cells can be reset to a more youthful state by exposing t...
03/24/2020
Old human cells rejuvenated with stem cell technology

Institute researcher Vittorio Sebastiano shows that aged human cells can be reset to a more youthful state by exposing them to Yamanaka factors, but not exposing them so much that they get reset to an embryonic state. Theoretically, if this is proven to be safe, in the future people might reset all the cells in their body through an injection or pill.http://med.stanford.edu/news/all-news/2020/03/old-human-cells-rejuvenated-with-stem-cell-technology.html

Old human cells can become more youthful by coaxing them to briefly express proteins used to make induced pluripotent cells, Stanford researchers and their colleagues have found. The finding may have implications for aging research.

03/07/2020

On Monday, Institute researcher Dr. Michal Caspi Tal will give an online webinar on "Coronaviruses for Non-Virologists." We will post information on how to Zoom in on Monday morning.

On World Cancer Day, ASCO releases its  Clinical Cancer Advances report that highlights the dramatic clinical trials res...
02/04/2020
Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

On World Cancer Day, ASCO releases its Clinical Cancer Advances report that highlights the dramatic clinical trials results using anti-#CD47 antibodies as an anti-cancer therapy. https://ascopubs.org/doi/10.1200/JCO.19.03141

Each year Clinical Cancer Advances: ASCO’s Annual Report on Progress Against Cancer highlights the most important clinical research advances of the past year, including the Advance of the Year, and identifies priority areas where ASCO believes research efforts should be focused moving forward. In ...

Institute researcher Michelle Monje, MD, PhD, profiled in a fascinating piece by Ludwig Cancer Research. https://www.lud...
10/01/2019
Ludwig Cancer Research

Institute researcher Michelle Monje, MD, PhD, profiled in a fascinating piece by Ludwig Cancer Research. https://www.ludwigcancerresearch.org/news-releases/aggressive-brain-cancers-tap-into-neural-wiring-to-thrive/?fbclid=IwAR27nWeE4Fm_4tTgkxg6ok2wN_8XvSu4EMn4vP7VGKB8VIKnibVuHCWgGxU

SEPTEMBER 27, 2019, New York— A team led by Michelle Monje of the Ludwig Center at Stanford has discovered that a group of brain tumors known as high-grade gliomas form synapses—or connections with neurons—and tap electrical signals from healthy nerve cells to drive their own growth. Interrupt...

Institute scientists invent a powerful new tool for biological discovery and  clinical application. https://med.stanford...
05/06/2019
New computational tool enables powerful molecular analysis of biomedical tissue samples

Institute scientists invent a powerful new tool for biological discovery and clinical application. https://med.stanford.edu/news/all-news/2019/05/computational-tool-enables-powerful-molecular-analysis-of-tissue-samples.html

Stanford researchers have developed a computational platform for analyzing the molecular behavior of individual cells in tissue samples, opening the door for new discoveries, diagnostics and treatments.

Agnieszka Czechowicz and her colleagues have created an antibody that could open up stem cell treatments for a wide vari...
02/07/2019
Antibody preparation for blood stem cell transplant

Agnieszka Czechowicz and her colleagues have created an antibody that could open up stem cell treatments for a wide variety of new diseases, make organ transplants safer without the need for matching donors and recipients. This is in mice right now, but if it works in humans it could be revolutionary.http://med.stanford.edu/stemcell/news/antibodyprep.html

A series of discoveries by researchers at the Stanford Institute for Stem Cell Biology and Regenerative Medicine (ISCBRM) might radically alter organ transplantation, gene therapy, the treatment of autoimmune diseases and many other blood and immune disorders. This week in the journal Nature Communi...

Our nearest living invertebrate relative shares its secrets about how the blood and immune system works.http://med.stanf...
12/07/2018
Sea invertebrate sheds light on evolution of human blood, immune systems

Our nearest living invertebrate relative shares its secrets about how the blood and immune system works.http://med.stanford.edu/news/all-news/2018/12/sea-invertebrate-sheds-light-on-evolution-of-human-blood-system.html

A lowly sea creature may provide a way to understand our own blood-forming system, improve our immune function and find new immune-associated tools for biological discovery, Stanford researchers say.

Hank Greeley shares his thoughts about gene-edited babies and the events in China. https://law.stanford.edu/2018/12/05/t...
12/06/2018
The First Gene-Edited Babies: A Discussion on the Legal and Ethical Questions with Stanford’s Hank Greely | Stanford Law School

Hank Greeley shares his thoughts about gene-edited babies and the events in China. https://law.stanford.edu/2018/12/05/the-first-gene-edited-babies-a-discussion-on-the-legal-and-ethical-questions-with-stanfords-hank-greely/

Last month, He Jiankui, a Chinese researcher, announced the birth of the world’s first gene-edited babies, whose DNA had been edited to reduce the

The first published results of the phase 1 clinical trial testing anti-CD47 therapy against cancer.http://med.stanford.e...
11/01/2018
Anti-CD47 cancer therapy safe, shows promise in small clinical trial

The first published results of the phase 1 clinical trial testing anti-CD47 therapy against cancer.

http://med.stanford.edu/news/all-news/2018/10/anti-cd47-cancer-therapy-safe-shows-promise-in-small-trial.html

An immunotherapy conceived at Stanford appeared safe in an early clinical trial. Half of the participants responded positively to the treatment, aimed at triggering macrophages to engulf cancer cells, the researchers reported.

The first official results out on the use of anti-CD47 antibodies against cancer. Good news!http://www.targetedonc.com/n...
06/05/2018
First-in-Class Anti-CD47 Antibody Induces Responses With Rituximab in R/R NHL

The first official results out on the use of anti-CD47 antibodies against cancer. Good news!
http://www.targetedonc.com/news/firstinclass-anticd47-antibody-induces-responses-with-rituximab-in-rr-nhl

According to initial results from a phase Ib/II study presented at the 2018 ASCO Annual Meeting, 50% of a small group of patients with relapsed or refractory non-Hodgkin lymphoma achieved responses from the combination of an anti-CD47 antibody plus rituximab.

An amazing, dramatic story of how institute scientists and other Stanford researchers pulled together to study a colleag...
05/08/2018
Stanford researchers map intricacies of lung cancer in one of their own

An amazing, dramatic story of how institute scientists and other Stanford researchers pulled together to study a colleague's lung cancer in pervasive detail.
http://med.stanford.edu/news/all-news/2018/05/stanford-researchers-map-lung-cancer-in-one-of-their-own.html

When James Spudich was diagnosed with lung cancer, researchers had a rare, and unexpected, opportunity to study healthy and diseased human tissue at an unprecedented level of detail.

This week saw a culmination of a huge effort to characterize the genomes of all major cancers, and a tool developed by t...
04/13/2018
PanCanTCGA | Department of Biomedical Data Science | Stanford Medicine

This week saw a culmination of a huge effort to characterize the genomes of all major cancers, and a tool developed by the institute's Aaron Newman, CIBERSORT, was used by a large number of the researchers who did this work. Congratulations to Aaron on creating a powerful and widely respected tool in cancer research.
http://med.stanford.edu/dbds/news/news-story-3.html

Stanford, CA (April 12, 2018)-- Last week, The Cancer Genome Atlas (TCGA) PanCan effort released a series of 27 papers. Published in various Cell journals, these papers mark the culmination and completion of the PanCancer Atlas Initiative (PanCan) and The Cancer Genome Atlas (TCGA) consortium. The l...

Kyle Loh and his colleagues have found lung stem cells in mice--next stop is human lung stem cells and regenerating dise...
11/14/2017
Researchers find lung stem cell, heal lung injury in mice

Kyle Loh and his colleagues have found lung stem cells in mice--next stop is human lung stem cells and regenerating diseased or damaged lung tissue, something that cannot be done short of a transplant now.
http://med.stanford.edu/news/all-news/2017/11/researchers-find-lung-stem-cell-heal-lung-injury-in-mice.html?linkId=44720172

Stanford scientists have found a cell that creates the two different compartments in the mouse lung. They hope their discovery could lead to better therapies for people with lung disease.

The challenge of moving from a economic model of treating disease by regular administration of drugs to one of a single ...
09/12/2017
New Gene-Therapy Treatments Will Carry Whopping Price Tags

The challenge of moving from a economic model of treating disease by regular administration of drugs to one of a single treatment that provides a lifetime cure.
"We recognize that most payers in the U.S. are not currently set up to support one-time therapies that generate long-term transformative benefits."
https://www.nytimes.com/2017/09/11/health/cost-gene-therapy-drugs.html?rref=collection%2Fsectioncollection%2Fhealth&action=click&contentCollection=health®ion=rank&module=package&version=highlights&contentPlacement=1&pgtype=sectionfront

Kymriah, approved recently by the F.D.A., with a $475,000 price tag, is first of a coming wave of treatments whose expected prices have alarmed economists, scientists and insurers.

A research group says that they can predict facial features from whole-genome sequencing, but it turns out that they are...
09/11/2017
Human Longevity Study Sparks Questions About Face Prediction Claims, Data Sharing, Role of Preprints

A research group says that they can predict facial features from whole-genome sequencing, but it turns out that they are using ancestry data to construct a profile that looks like the population average with that background. Stanford ethicist Hank Greely says this is low on his list of threats to privacy. https://www.genomeweb.com/sequencing/human-longevity-study-sparks-questions-about-face-prediction-claims-data-sharing-role?utm_source=Sailthru&utm_medium=email&utm_campaign=GWDN%20Mon%20AM%202017-09-11&utm_term=GW%20Daily%20News%20Bulletin

Researchers have argued that the facial prediction claims are overblown and serve Human Longevity's financial interests in proprietary genomic databases.

Address

265 Campus Dr
Stanford, CA
94305

Alerts

Be the first to know and let us send you an email when Stanford Institute for Stem Cell Biology and Regenerative Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Nearby universities


Other Colleges & Universities in Stanford

Show All

Comments

It’s the last week to apply for the Synthego #GenomeEngineer Innovation Grant. Tell us about your vision to use genome engineering to change the world and we can help you make it a reality. Get your application in before March 29th: https://hubs.ly/H0h7dK20
🔴#Tissue_Science_Conference_2019🔴 🔴Looking forward to deliver an invited talk on #Biomaterials #Tissue_Engineering later at Tissue Science 2019 meeting🔴 Download the brochure here: 👇http://tissuescience.alliedacademies.com/brochure-download #biofabrication #3D_Printing #Regenerative_medicine #Stem_cells
Dear All, Be the part of our highly exciting multidisciplinary International Book Project. Contribute in it as well as encourage yours research student to participate in it All are informed that we are going to publish a life science book with international publisher [Editors: Poonam Singh (INDIA) , Amit Rastog (INDIA), Rocktotpal Konwarh (ETHOPIA)]. Publisher : CRC, PRESS ( TAYLOR AND FRANSIS GROUP). Book Title: New Frontiers in BIosciences and BIoengineering We have 7 major section in our Book; Plant Sciences and Plant Biotechnoligy, Enzyme Technology Neurodegenerative disease and Neuroscience Nanobiotechnology Regenerative medicines and Personalised medicines Pharmaceutical Sciences miscellaneous We have response from Japan, Malasiya, Cuba, France, India,Ethiopia and also waiting for other scientist for contibution. CSIR SCIENTISTS ARE ALSO CONTRIBUTING IN OUR BOOK PROJECT. For this purpose you all are invited to send a valuable book chapter (minimum 20 page length ) on any theme related to life Sciences including biotechnology, microbiology, Pharmaceutical Sciences, Regenative medicines, Personalized Medicine , Pharmacogenomics , Pharmacogenetics, Nanotechnology, neuroscience, Plant Science, Plant biotechnology and many more. You can send a valuable book chapter till the end of this year. (There will not be any fee to authors). Recently we published a book on Plant Biomass and Energy Solution with Discovery International Publisher. Waiting for yours response.Thanks and best regards. Contact: 07084373821
Foreign policy news.US ) India’s engagement with APEC through the Indo-Pacific foreign policy By Srimal Fernando, Megha Gupta and Sharon Jose Asia, Asia, Oceania and Americas are important geopolitical spaces of the Pacific Rim encircling some of the wealthiest counties of the world. Of the sixty five nations present in this rim, twenty one nations are a part of the Asia-Pacific Economic Cooperation (APEC). APEC came into force to integrate the economies of the Asia Pacific region through promotion of trade and sustainable development. This association was formed a little less than thirty years ago and is home to around 2.8 billion people (APEC, 2017).
Hi all I create Glass Art. The Science of Cells. I decided to do a Limited Edition Giclée print of my pieces for those who love the Cell image. I thought I'd share my work with you - thanks.